Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship between JAK2(V617F) mutation and dermatomyositis-a case report and literature review.

Clinical rheumatology - 1 Mar 2021

Xu Qin, Jin Xuexiao, Jiang Yu, Dang Xin, Han Yongmei

Abstract excerpt

The JAK family (JAK1, JAK2, JAK3, and TYK2) have recently emerged as a potential therapeutic management in controlling severe and refractory dermatomyositis. Meanwhile, the progress in the discovery of JAK blockers is significant, with an increasing number of selective JAK inhibitors reported and some are in or prepare for clinical trials. However, the importance of each JAK in dermatomyositis is unclear, which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatomyositis
Share to Janus Kinase 2
Share to Janus Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myeloproliferative Disorders

Source

Identifiers

PMID: 32676918
DOI: 10.1007/s10067-020-05286-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship between JAK2(V617F) mutation and dermatomyositis-a case report and literature review.PMID 32676918Read ↗

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.Semantic proximity Read ↗

Idiopathic myelofibrosis and pyoderma gangrenosum involving a mutation of Janus kinase 2 (JAK2V617F), showing poor prognosis.Semantic proximity Read ↗

Systemic mastocytosis associated with essential thrombocythemia.Semantic proximity Read ↗

Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.Semantic proximity Read ↗

Secondary hemophagocytic lymphohistiocytosis: a case report.Semantic proximity Read ↗

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesSemantic proximity Read ↗

Unprecedented coexistence of autoinflammatory myositis and chronic thrombosis with heterozygotic M694V mutation: An atypical presentation of familial Mediterranean fever.Semantic proximity Read ↗

Common cutaneous signs unmasking a severe hematological disorder: GATA2 deficiency.Semantic proximity Read ↗

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.Semantic proximity Read ↗

A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.